Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemic features and potential impact of vaccine campaigns on the 2025 chikungunya outbreak in southern China: a mathematical modelling study.

New microbes and new infections·2026
Same author

Clinical Outcomes of Immunosuppressant drugs in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta Analysis.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2026
Same author

The 2026 Ebola Outbreak and Mass Gathering Risk.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

<i>In vitro</i> activity of imipenem-relebactam against carbapenem-resistant <i>Pseudomonas aeruginosa</i>: correlation with carbapenem MICs and association with <i>β</i>-lactamase classes.

Frontiers in microbiology·2026
Same author

Hantavirus at the hajj: decoupling perceived risk from epidemiological reality.

Journal of travel medicine·2026
Same author

Elephant Rounds: a structured multi-disciplinary huddle to operationalise systems thinking in infection prevention and control.

The Journal of hospital infection·2026

Related Experiment Video

Updated: Jul 7, 2026

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

Therapeutic options for human brucellosis.

Jaffar A Al-Tawfiq1

  • 1Internal Medicine Services Division Dhahran Health Center, Saudi Aramco Medical Services Organization, Saudi Aramco, Dhahran, Saudi Arabia. jaffar.tawfiq@aramco.com

Expert Review of Anti-Infective Therapy
|February 7, 2008
PubMed
Summary

Human brucellosis, a common zoonotic disease, often requires combination therapy to prevent relapses. Streptomycin with tetracycline shows better outcomes than doxycycline-rifampin, with longer or triple therapy beneficial for focal cases.

More Related Videos

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
15:29

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Published on: August 5, 2016

Related Experiment Videos

Last Updated: Jul 7, 2026

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
15:29

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Published on: August 5, 2016

Area of Science:

  • Zoonotic Diseases
  • Infectious Disease Epidemiology
  • Microbiology and Immunology

Background:

  • Human brucellosis is a prevalent zoonotic disease with potential bioweapon applications.
  • Monotherapy for brucellosis leads to high relapse rates, necessitating combination regimens.
  • Brucellosis treatment strategies are evolving due to antibiotic resistance and disease severity.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for human brucellosis.
  • To compare the efficacy of different antimicrobial combination regimens.
  • To explore novel treatment modalities and preventative measures for brucellosis.

Main Methods:

  • Systematic review and meta-analysis of existing studies on brucellosis treatment.
  • Analysis of prospective studies comparing different drug combinations.
  • Evaluation of emerging therapies including microparticle drug delivery and new antibiotics.

Main Results:

  • Intramuscular streptomycin plus oral tetracycline demonstrated lower relapse rates than doxycycline-rifampin.
  • Longer duration and triple antimicrobial therapy improved outcomes, particularly in focal brucellosis.
  • Emerging treatments like gentamicin microparticles and tigecycline show future promise.

Conclusions:

  • Combination therapy is essential for effective brucellosis treatment, with streptomycin-tetracycline being a preferred regimen.
  • Extended or triple therapy is recommended for complex or focal brucellosis cases.
  • Further research into novel antibiotics, drug delivery systems, and vaccines is crucial for controlling brucellosis.